• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Emergence of multidrug resistant influenza A(H1N1)pdm09 virus variants in an immunocompromised child treated with oseltamivir and zanamivir

tetano

Editor, Senior Moderator
J Infect Dis. 2015 May 5. pii: jiv245. [Epub ahead of print]
[h=1]Emergence of multidrug resistant influenza A(H1N1)pdm09 virus variants in an immunocompromised child treated with oseltamivir and zanamivir.[/h] Tamura D[SUP]1[/SUP], DeBiasi RL[SUP]2[/SUP], Okomo-Adhiambo M[SUP]1[/SUP], Mishin VP[SUP]1[/SUP], Campbell AP[SUP]1[/SUP], Loechelt B[SUP]3[/SUP], Wiedermann BL[SUP]4[/SUP], Fry AM[SUP]1[/SUP], Gubareva LV[SUP]1[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Prolonged treatment of an immunocompromised child with oseltamivir and zanamivir for A(H1N1)pdm09 virus infection led to the emergence of viruses carrying H275Y and/or E119G in the neuraminidase. When phenotypically evaluated by neuraminidase inhibition, the dual H275Y-E119G substitution caused highly reduced inhibition by four neuraminidase inhibitors including oseltamivir, zanamivir, peramivir and laninamivir.
Published by Oxford University Press on behalf of the Infectious Diseases Society of America 2015. This work is written by (a) US Government employee(s) and is in the public domain in the US.


PMID: 25943200 [PubMed - as supplied by publisher]
 
Back
Top Bottom